TSH ≥30 mU/L may not be necessary for successful (131)I remnant ablation in patients with differentiated thyroid cancer

PURPOSE: To determine whether thyroid-stimulating hormone level ≥ 30 mU/L is necessary for radioiodine ((131)I) remnant ablation (RRA) in patients with differentiated thyroid cancer (DTC), as well as its influencing factors and predictors. METHODS: A total of 487 DTC patients were retrospectively en...

Descripción completa

Detalles Bibliográficos
Autores principales: Ju, Nianting, Hou, Liying, Song, Hongjun, Qiu, Zhongling, Wang, Yang, Sun, Zhenkui, Luo, Quanyong, Shen, Chentian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305696/
https://www.ncbi.nlm.nih.gov/pubmed/37022724
http://dx.doi.org/10.1530/ETJ-22-0219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305696/
https://www.ncbi.nlm.nih.gov/pubmed/37022724
http://dx.doi.org/10.1530/ETJ-22-0219

Ejemplares similares